PHAXIAM Therapeutics S.A. (PHXM)
NASDAQ: PHXM
· Real-Time Price · USD
3.10
-0.17 (-5.20%)
At close: Mar 08, 2024, 10:00 PM
PHAXIAM Therapeutics S.A. Revenue
PHAXIAM Therapeutics S.A. reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2023, PHAXIAM Therapeutics S.A. generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
49
Market Cap
19.86M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | -100.00% |
| Dec 31, 2019 | 5.28M | +Infinity% |
| Dec 31, 2018 | 0 | -100.00% |
| Dec 31, 2017 | 3.36M | -82.94% |
| Dec 31, 2016 | 19.72M | +82.99% |
| Dec 31, 2015 | 10.78M | +146.65% |
| Dec 31, 2014 | 4.37M | +142.45% |
| Dec 31, 2013 | 1.8M | -1.96% |
| Dec 31, 2012 | 1.84M | +Infinity% |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | n/a |